Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Omada Health Sees FY2025 Sales $235.000M-$241.000M vs $221.514M Est

Author: Benzinga Newsdesk | August 07, 2025 03:10pm

Financial Outlook

For the year ending December 31, 2025, Omada expects:

  • Revenue in the range of $235 million to $241 million
  • Adjusted EBITDA loss in the range of $9 million to $5 million

Posted In: OMDA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist